Demand patterns for HIV-tests in general practice: Information collected by sentinel networks in 5 European countries

This study describes a p. year international data collection on the demand pattern for HIV-antibody tests in general practice recorded by 6 sentinel networks in 5 European countries. The purpose of the recording was to evaluate the use of HIV-antibody testing by general practitioners and the demand for testing among the general population. Sentinel networks of general practitioners are a possible and available instrument for monitoring the perception of the HIV-test, and indirectly of the threat of the HIV-epidemic by the public and by the general practitioners (GPs). Differences were found between the countries in the frequency of testing, the person asking the test and the reason for testing. Possible explanatory factors, such as differences in the routine testing of specific groups, differences in the training and in the role of the GP, differences in the characteristics of prevention policy, are discussed. The European comparison also offers the opportunity to reflect on common medical practice in dealing with demands for HIV-tests.     

Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV)

The Medical Outcomes Study HIV Health Survey (MOS-HIV) is a brief, comprehensive measure of health-related quality of life (HRQoL) used extensively in human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS). The 35-item questionnaire includes ten dimensions (health perceptions, pain, physical, role, social and cognitive functioning, mental health, energy, health distress and quality of life (QoL)) and takes approximately 5 minutes to complete. Subscales are scored on a 0–100 scale (a higher score indicates better health) and physical and mental health summary scores can be generated. The MOS-HIV has been shown to be internally consistent, correlate with concurrent measures of health, discriminate between distinct groups, predict future outcomes and be responsive to changes over time. Limited experience suggests acceptable reliability and validity in women, injecting drug users and African–American and lower socioeconomic status patients. The MOS-HIV is available in 14 languages and has been included as a secondary outcome measure in numerous clinical trials for all stages of disease. In several studies it has detected significant differences between treatments; in some cases concordant with conventional end-points and, in others, discordant. The interpretation of scores is facilitated by an explanation in terms meaningful to the intended audience. Research is needed to compare the MOS-HIV to other strategies for HRQoL assessment in early HIV disease.     

温州市艾滋病流行特征及流行趋势分析

目的 分析温州市1985～2000年HIV／AIDS流行现状及影响因素，为采取有效控制措施提供依据。方法 分析全市的艾滋病监测及实验室资料。结果 1985年发现首例HIV抗体阳性，至2000年底累计发现感染者124例，发病27例，死亡16例。感染者以青壮年为主，男女比例为3．28：1，静脉推注吸毒和性接触是主要传播途径。结论 预计今后几年温州市高危人群中HIV感染者将大幅度增长，必须采取有效措施预防和控制艾滋病。     

预防艾滋病毒性传播的杀微生物剂的研究现状

杀微生物剂的应用是预防艾滋病毒性传播的重要途径.本文阐明了艾滋病毒的性传播机制和杀微生物剂的作用机理,进一步综述了杀微生物剂的类型及其发展前景.     

HIV/AIDS痰瘀病机探讨

艾滋病（AIDS-Acquired Immunodeficiency Syndrome）是一种严重危害人类健康、传播速度快、病死率极高的传染病。     

印度结核病流行病学:综述

印度的结核病形势可以用高患病率、高发病率高传染率来描述。自二十世纪50年代以来在印度不同地区进行的疾病监测报告显示:涂阳肺结核患病率为0.6-7.6/1000,培阳肺结核患病率为1.7-9.8/1000,培阳和/或涂阳结核患病率为1.8-12.7/1000。从已进行的有限的研究资料分析,涂阳肺结核的发病率在1.0-1.6/1000之间,培阳肺结核发病率在1.0-2.5/1000之间。根据不同时期在不同地区进行的结核菌素监测估计,结核年感染率(ARTI)为1-2%。在2000-2003年进行的全国范围研究估计,平均ARTI为1.5%。多数在第3级卫生保健中心进行的研究显示在结核病例中人类免疫缺陷病毒(HIV)血清阳性率在增加,不同研究的结果介于0.4%-28.8%之间。新病例中耐多药(MDR)率相对较低,约0.5-5.3%之间。但在复治病例中MDR为8%-67%。     

几种抗艾滋病中药有效成分对解脲支原体和白色念珠菌体外抑制作用的实验研究

目的筛选对解脲支原体和白色念珠菌体外有明显抑制作用的抗H IV中药有效成分,为治疗H IV继发感染或性病奠定基础。方法以微量稀释法测定9种中药有效成分对解脲支原体和白色念珠菌的M IC50和M IC90,同时测定其中6种中药有效成分对H IV-1的EC50和TI值。结果所测药物对解脲支原体、白色念珠菌及H IV-1均有一定的抑制作用,对解脲支原体和白色念珠菌作用最好的分别是三七总皂苷、三七叶皂苷和化合物A,化合物A对H IV-1的抑制作用最好,其EC50为0.09,TI值大于10 000。结论化合物A对解脲支原体、白色念珠菌及H IV-1的抑制效果最好,值得进一步研究。     

Detection of Epstein Barr virus in an hepatic leiomyomatous neoplasm in an adult human immunodeficiency virus 1-infected patient

We report the first case of a human immunodeficiency virus (HIV)-related primary hepatic leiomyoma in an adult patient. The diagnosis was made at autopsy and confirmed by immunohistochemistry. Epstein Barr virus (EBV) was identified in tumour cells by in situ hybridization. Review of the literature revealed 13 cases of visceral myogenic tumours occuring in acquired immunodeficiency syndrome children, and only 2 cases in adults. One was a spinal epidural leiomyoma, the other multiple smooth muscle tumours of the colon and adrenal gland. This is the first report of EBV in smooth muscle neoplastic cells in an HIV-infected adult patient.     

南京口岸1987—1993年艾滋病监测报告

本文报道了南京卫生检疫局1987～1993连续7年对南京口岸重点人群进行艾滋病监测的情况．7年来南京局共监测各类标本43085份，在外籍留学生中检出HIV感染者2例，另外还检出4份进口人血丙种球旦白HIV抗体阳性．该局对检出的2侧HIV感染者及4份阳性进口人血丙种球旦白进行了游行病学调查和处理．并对艾滋病监测管理的有关问题进行了探讨．     

Human immunodeficiency virus (HIV)-related chronic relapsing inflammatory demyelinating polyneuropathy with multifocal unusual onion bulbs in sural nerve biopsy

Summary This is obviously the first report on a case with a spontaneous sensu strictu relapsing variant of human immunodeficiency virus (HIV)-related polyneuropathy. Its manifestation preceded LAS. Intrathecal HIV-antibodies developed between the most severe third and fourth episode. Analysis of sural nerve biopsy was consistent with a multifocally accentuated chronic inflammatory demyelination, characterized by unusual onion bulb-like Schwann cell formations with irregular voluminous layers, electron density, aggregation of filaments, multiple indented nuclei, and numerous enclosed collagen pockets. A direct or immune-mediated indirect specific influence on Schwann cell morphology by HIV might be discussed. Virus-like particles and ultrastructural markers of HIV were not detectable.